Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sherif T Abuserewa"'
Publikováno v:
Cureus
Yellow nail syndrome is an extremely rare syndrome that presents with a clinical triad of thickened yellow nails, lymphedema, and recurring pulmonary manifestations (pleural effusion, chronic cough, or bronchiectasis), usually in the population above
Publikováno v:
Cureus
Pulmonary hypertension (PH) in patients with chronic obstructive pulmonary disease (COPD) is associated with an increase in the risk of COPD exacerbation, increased hospitalization, and worse survival in this patient population. No specific treatment
Autor:
Richard Duff, Sherif T Abuserewa
Publikováno v:
Cureus
Cerebral sinus venous thrombosis (CSVT) is a rare disorder that presents with highly variable neurological manifestations ranging from headache, confusion, seizures, coma to stroke-like symptoms. It predominantly affects young adults and children, wi
Publikováno v:
Cureus
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was aimed at minimizing inflammation and slowing the progression of
Publikováno v:
Cureus
Acute otomastoiditis is a potentially life-threatening condition. It is relatively uncommon in elderly patients and is usually seen as a complication of acute otitis media. Limited studies are available on this uncommon disease in the elderly, and th
Autor:
Sherif T Abuserewa, Richard Duff
Publikováno v:
Cureus
The diagnosis of pulmonary embolism (PE) needs clinical manifestations and radiological findings. CT angiography (CTA) of pulmonary vessels is the gold standard of diagnosis of PE. However, endobronchial ultrasound (EBUS) can be a reliable and accura
Autor:
Marshall Hyden, Adam Burdorf, Brian D. Lowes, Ahmed Selim, Ronald Zolty, Douglas Stoller, Sherif T Abuserewa
Publikováno v:
Journal of Cardiac Failure. 25:S45
Background Exercise-induced pulmonary hypertension (EiPH) can cause a significant deterioration in quality of life as well as a decrease in life expectancy. Additionally, EiPH may precede the development of manifest PH in a proportion of patients. In
Autor:
Ahmed Selim, Douglas Stoller, Marshall Hyden, Ronald Zolty, Sherif T Abuserewa, Brian D. Lowes, Adam Burdorf
Publikováno v:
Journal of Cardiac Failure. 25:S45
Background Pulmonary hypertension (PH) in patients with COPD is associated with an increase in the risk of COPD exacerbation, increased hospitalization and worse survival in this patient population. The majority of patients with COPD have a mild degr